$OBMP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in THERALINK TECHNOLOGIES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in THERALINK TECHNOLOGIES, INC.. Get notifications about new insider transactions in THERALINK TECHNOLOGIES, INC. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | Director | Option Exercise | A | 0.00 | 241 | 0 | 241 | |
| Jun 09 2020 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | Director | Option Exercise | A | 0.00 | 241 | 0 | 241 | |
| May 08 2020 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | CEO and CFO | Grant | A | 0.06 | 283,334 | 17,000 | 290,001 | 6.7 K to 290 K (+4,249.80 %) |
| May 08 2020 | OBMP | OncBioMune Pharmac ... | HEAD JONATHAN FREDERICK | Director | Grant | A | 0.06 | 166,667 | 10,000 | 189,236 | 22.6 K to 189.2 K (+738.48 %) |
| Apr 30 2019 | OBMP | OncBioMune Pharmac ... | HOLCOMB ROBERT NEAL | Director | Option Exercise | A | 0.01 | 3,000,000 | 30,000 | 3,000,000 | |
| Apr 30 2019 | OBMP | OncBioMune Pharmac ... | RICE CHARLES L JR | Director | Option Exercise | A | 0.01 | 3,000,000 | 30,000 | 3,000,000 | |
| Apr 30 2019 | OBMP | OncBioMune Pharmac ... | Hoverman Daniel S. | Director | Option Exercise | A | 0.01 | 3,000,000 | 30,000 | 3,000,000 | |
| Apr 30 2019 | OBMP | OncBioMune Pharmac ... | Barnett Brian Gill | Director | Option Exercise | A | 0.01 | 8,347,245 | 100,167 | 8,347,245 | |
| Apr 30 2019 | OBMP | OncBioMune Pharmac ... | Barnett Brian Gill | Director | Option Exercise | A | 0.01 | 8,347,245 | 100,167 | 8,347,245 | |
| May 11 2018 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | Chief Financial Off ... | Option Exercise | A | 0.01 | 3,000,000 | 40,500 | 5,000,000 | |
| May 11 2018 | OBMP | OncBioMune Pharmac ... | Hoverman Daniel S. | Director | Option Exercise | A | 0.01 | 3,000,000 | 40,500 | 3,350,000 | |
| May 11 2018 | OBMP | OncBioMune Pharmac ... | RICE CHARLES L JR | Director | Option Exercise | A | 0.01 | 3,000,000 | 40,500 | 3,350,000 | |
| Apr 20 2017 | OBMP | OncBioMune Pharmac ... | RICE CHARLES L JR | Director | Option Exercise | A | 0.27 | 350,000 | 94,500 | 350,000 | |
| Apr 20 2017 | OBMP | OncBioMune Pharmac ... | RICE CHARLES L JR | Director | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Apr 20 2017 | OBMP | OncBioMune Pharmac ... | Hoverman Daniel S. | Director | Option Exercise | A | 0.27 | 350,000 | 94,500 | 350,000 | |
| Apr 20 2017 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | Chief Financial Off ... | Option Exercise | A | 0.25 | 2,000,000 | 500,000 | 2,000,000 | |
| Mar 13 2017 | OBMP | OncBioMune Pharmac ... | HEAD JONATHAN FREDERICK | Chief Executive Off ... | Buy | J | 0.00 | 2,892,000 | 0 | 2,892,000 | 0 to 2.9 M |
| Feb 19 2016 | OBMP | OncBioMune Pharmac ... | Hoverman Daniel S. | Director | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Feb 04 2016 | OBMP | OncBioMune Pharmac ... | HEAD JONATHAN FREDERICK | Chief Executive Off ... | Sell | S | 0.00 | 1,025,000 | 1,025 | 16,926,078 | 18 M to 16.9 M (-5.71 %) |
| Feb 04 2016 | OBMP | OncBioMune Pharmac ... | HEAD JONATHAN FREDERICK | Chief Executive Off ... | Grant | A | 0.00 | 17,951,078 | 0 | 17,951,078 | 0 to 18 M |
| Feb 04 2016 | OBMP | OncBioMune Pharmac ... | ELLIOT ROBERT LANGE JR | Director | Sell | S | 0.00 | 1,025,000 | 1,025 | 16,926,079 | 18 M to 16.9 M (-5.71 %) |
| Feb 04 2016 | OBMP | OncBioMune Pharmac ... | ELLIOT ROBERT LANGE JR | Director | Grant | A | 0.00 | 17,951,079 | 0 | 17,951,079 | 0 to 18 M |
| Feb 04 2016 | OBMP | OncBioMune Pharmac ... | KUCHARCHUK ANDREW ALBERT | CFO & President | Grant | A | 0.00 | 5,000,000 | 0 | 5,000,000 | 0 to 5 M |
| Nov 20 2015 | OBMP | OncBioMune Pharmac ... | RICE CHARLES L JR | Director | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
| Sep 15 2015 | OBMP | OncBioMune Pharmac ... | Leone Group, LLC | 10% Owner | Buy | J | 0.00 | 666,666 | 2,000 | 1,648,831 | 982.2 K to 1.6 M (+67.88 %) |
| Sep 15 2015 | OBMP | OncBioMune Pharmac ... | American Capital Ventures, Inc ... | 10% Owner | Buy | J | 0.00 | 666,666 | 2,000 | 1,648,831 | 982.2 K to 1.6 M (+67.88 %) |
| Jun 26 2015 | OBMP | OncBioMune Pharmac ... | Leone Group, LLC | 10% Owner | Buy | J | 0.00 | 3,188,546 | 9,566 | 136,082,500 | 132.9 M to 136.1 M (+2.40 %) |
| Jun 26 2015 | OBMP | OncBioMune Pharmac ... | Leone Group, LLC | 10% Owner | Sell | S | 0.00 | 17,774,136 | 1,777 | 132,893,954 | 150.7 M to 132.9 M (-11.80 %) |
| Jun 26 2015 | OBMP | OncBioMune Pharmac ... | American Capital Ventures, Inc ... | 10% Owner | Buy | J | 0.00 | 3,188,546 | 9,566 | 136,082,500 | 132.9 M to 136.1 M (+2.40 %) |
| Jun 26 2015 | OBMP | OncBioMune Pharmac ... | American Capital Ventures, Inc ... | 10% Owner | Sell | S | 0.00 | 17,774,136 | 1,777 | 132,893,954 | 150.7 M to 132.9 M (-11.80 %) |
| May 21 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Buy | P | 0.00 | 17,774,136 | 0 | 35,848,272 | 18.1 M to 35.8 M (+98.34 %) |
| May 21 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Buy | P | 0.00 | 17,774,136 | 0 | 18,074,136 | 300 K to 18.1 M (+5,924.71 %) |
| Apr 17 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Buy | P | 0.00 | 17,774,136 | 0 | 35,848,272 | 18.1 M to 35.8 M (+98.34 %) |
| Apr 17 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Buy | P | 0.00 | 17,774,136 | 0 | 18,074,136 | 300 K to 18.1 M (+5,924.71 %) |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | VP, Investor Relati ... | Sell | S | 0.00 | 2,100,000 | 210 | 0 | 2.1 M to 0 (-100.00 %) |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | VP, Investor Relati ... | Sell | S | 0.00 | 2,100,000 | 210 | 2,100,000 | 4.2 M to 2.1 M (-50.00 %) |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Buy | P | 0.00 | 300,000 | 30 | 300,000 | 0 to 300 K |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Sell | S | 0.00 | 300,000 | 30 | 0 | 300 K to 0 (-100.00 %) |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Sell | S | 0.00 | 6,375,000 | 638 | 0 | 6.4 M to 0 (-100.00 %) |
| Mar 18 2015 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Chief Executive Off ... | Sell | S | 0.00 | 6,375,000 | 638 | 6,375,000 | 12.8 M to 6.4 M (-50.00 %) |
| Apr 08 2013 | OBMP | OncBioMune Pharmac ... | Durrant Cameron | President, CEO, CFO ... | Sell | P | 0.01 | 4,250,000 | 51,000 | 0 | 4.3 M to 0 (-100.00 %) |
| Apr 08 2013 | OBMP | OncBioMune Pharmac ... | DIETRICH Constantin | Director | Buy | P | 0.01 | 4,250,000 | 51,000 | 4,250,000 | 0 to 4.3 M |
| Apr 08 2013 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | VP, Investor Relati ... | Buy | P | 0.02 | 400,000 | 9,600 | 1,400,000 | 1000 K to 1.4 M (+40.00 %) |
| Apr 08 2013 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | VP, Investor Relati ... | Buy | P | 0.01 | 600,000 | 7,200 | 1,000,000 | 400 K to 1000 K (+150.00 %) |
| Apr 08 2013 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | VP, Investor Relati ... | Sell | S | 0.01 | 600,000 | 7,200 | 0 | 600 K to 0 (-100.00 %) |
| Mar 04 2011 | OBMP | OncBioMune Pharmac ... | Rodriguez Jorge Enrique | VP & Chief Commerci ... | Option Exercise | A | 1.14 | 420,000 | 478,800 | 420,000 | |
| Mar 04 2011 | OBMP | OncBioMune Pharmac ... | Tousley David L. | Treasurer Secretary ... | Option Exercise | A | 1.14 | 690,000 | 786,600 | 690,000 | |
| Nov 04 2010 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | President Secretary ... | Sell | J | 0.00 | 3,700,000 | 0 | 600,000 | 4.3 M to 600 K (-86.05 %) |
| Jul 08 2010 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | President Secretary ... | Sell | S | 0.01 | 1,050,000 | 12,600 | 4,300,000 | 5.4 M to 4.3 M (-19.63 %) |
| May 28 2010 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | President Secretary ... | Sell | S | 0.01 | 4,650,000 | 55,800 | 5,350,000 | 10 M to 5.4 M (-46.50 %) |
| Nov 05 2008 | OBMP | OncBioMune Pharmac ... | CARUSONE JOSEPH | President Secretary ... | Buy | P | 0.10 | 400,000 | 40,000 | 400,000 | 0 to 400 K |
Page: 1